179 related articles for article (PubMed ID: 33648524)
1. Splicing factors control triple-negative breast cancer cell mitosis through SUN2 interaction and sororin intron retention.
Koedoot E; van Steijn E; Vermeer M; González-Prieto R; Vertegaal ACO; Martens JWM; Le Dévédec SE; van de Water B
J Exp Clin Cancer Res; 2021 Mar; 40(1):82. PubMed ID: 33648524
[TBL] [Abstract][Full Text] [Related]
2. The oncogenic kinase NEK2 regulates an RBFOX2-dependent pro-mesenchymal splicing program in triple-negative breast cancer cells.
Naro C; De Musso M; Delle Monache F; Panzeri V; de la Grange P; Sette C
J Exp Clin Cancer Res; 2021 Dec; 40(1):397. PubMed ID: 34930366
[TBL] [Abstract][Full Text] [Related]
3. SNW1 enables sister chromatid cohesion by mediating the splicing of sororin and APC2 pre-mRNAs.
van der Lelij P; Stocsits RR; Ladurner R; Petzold G; Kreidl E; Koch B; Schmitz J; Neumann B; Ellenberg J; Peters JM
EMBO J; 2014 Nov; 33(22):2643-58. PubMed ID: 25257309
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
5. Sororin pre-mRNA splicing is required for proper sister chromatid cohesion in human cells.
Watrin E; Demidova M; Watrin T; Hu Z; Prigent C
EMBO Rep; 2014 Sep; 15(9):948-55. PubMed ID: 25092791
[TBL] [Abstract][Full Text] [Related]
6. Human cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion.
Zanini IM; Soneson C; Lorenzi LE; Azzalin CM
J Cell Sci; 2017 Feb; 130(4):767-778. PubMed ID: 28062851
[TBL] [Abstract][Full Text] [Related]
7. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
[TBL] [Abstract][Full Text] [Related]
8. Functional genomics identifies a requirement of pre-mRNA splicing factors for sister chromatid cohesion.
Sundaramoorthy S; Vázquez-Novelle MD; Lekomtsev S; Howell M; Petronczki M
EMBO J; 2014 Nov; 33(22):2623-42. PubMed ID: 25257310
[TBL] [Abstract][Full Text] [Related]
9. SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1.
Deng L; Liao L; Zhang YL; Yang SY; Hu SY; Andriani L; Ling YX; Ma XY; Zhang FL; Shao ZM; Li DQ
Sci Adv; 2024 Apr; 10(14):eadj4009. PubMed ID: 38569025
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.
Wang S; Oh DY; Leventaki V; Drakos E; Zhang R; Sahin AA; Resetkova E; Edgerton ME; Wu W; Claret FX
Cancer Lett; 2019 Nov; 465():12-23. PubMed ID: 31473252
[TBL] [Abstract][Full Text] [Related]
11. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
Li M; Li A; Zhou S; Lv H; Yang W
J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
[TBL] [Abstract][Full Text] [Related]
12. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
[TBL] [Abstract][Full Text] [Related]
13. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
14. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
[TBL] [Abstract][Full Text] [Related]
15. SMC1 promotes epithelial-mesenchymal transition in triple-negative breast cancer through upregulating Brachyury.
Li K; Ying M; Feng D; Chen Y; Wang J; Wang Y
Oncol Rep; 2016 Apr; 35(4):2405-12. PubMed ID: 26781859
[TBL] [Abstract][Full Text] [Related]
16. CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer.
Black JL; Harrell JC; Leisner TM; Fellmeth MJ; George SD; Reinhold D; Baker NM; Jones CD; Der CJ; Perou CM; Parise LV
Breast Cancer Res Treat; 2015 Jul; 152(2):337-46. PubMed ID: 26105795
[TBL] [Abstract][Full Text] [Related]
17. Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells.
Ling Y; Cao Q; Liu Y; Zhao J; Zhao Y; Li K; Chen Z; Du X; Huo X; Kang H; Chen Z
Breast Cancer; 2021 Mar; 28(2):368-378. PubMed ID: 33047272
[TBL] [Abstract][Full Text] [Related]
18. Regulation of sororin by Cdk1-mediated phosphorylation.
Dreier MR; Bekier ME; Taylor WR
J Cell Sci; 2011 Sep; 124(Pt 17):2976-87. PubMed ID: 21878504
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer.
Hua K; Deng X; Hu J; Ji C; Yu Y; Li J; Wang X; Fang L
J Exp Clin Cancer Res; 2020 Apr; 39(1):58. PubMed ID: 32248842
[TBL] [Abstract][Full Text] [Related]
20. MiR-181c suppresses triple-negative breast cancer tumorigenesis by targeting MAP4K4.
Xie D; Li S; Wu T; Wang X; Fang L
Pathol Res Pract; 2022 Feb; 230():153763. PubMed ID: 35026645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
